MAPK1 c.961G>A ;(p.D321N)

Variant ID: 22-22127167-C-T

NM_002745.4(MAPK1):c.961G>A;(p.D321N)

This variant was identified in 33 publications

View GRCh38 version.




Publications:


Automated optimisation of solubility and conformational stability of antibodies and proteins.

Nature Communications
Rosace, Angelo A; Bennett, Anja A; Oeller, Marc M; Mortensen, Mie M MM; Sakhnini, Laila L; Lorenzen, Nikolai N; Poulsen, Christian C; Sormanni, Pietro P
Publication Date: 2023-04-06

Variant appearance in text: MAPK1: D321N
PubMed Link: 37024501
Variant Present in the following documents:
  • 41467_2023_37668_MOESM13_ESM.xlsx, sheet 1
View BVdb publication page



Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics
Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q
Publication Date: 2022-11-04

Variant appearance in text: MAPK1: 961G>A; Asp321Asn
PubMed Link: 36333792
Variant Present in the following documents:
  • 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.

Cancers
Cheng, Yuxi Y; Chen, Juan J; Shi, Yuxin Y; Fang, Xiaodan X; Tang, Zhangui Z
Publication Date: 2022-09-23

Variant appearance in text: MAPK1: D321N
PubMed Link: 36230547
Variant Present in the following documents:
  • Main text
  • cancers-14-04625.pdf
View BVdb publication page



Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning.

Bmc Biology
Hou, Chao C; Li, Yuxuan Y; Wang, Mengyao M; Wu, Hong H; Li, Tingting T
Publication Date: 2022-07-14

Variant appearance in text: PRKM1: D321N
PubMed Link: 35836176
Variant Present in the following documents:
  • 12915_2022_1364_MOESM6_ESM.xlsx, sheet 3
View BVdb publication page



Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications
Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX
Publication Date: 2022-06-15

Variant appearance in text: MAPK1: D321N
PubMed Link: 35705558
Variant Present in the following documents:
  • 41467_2022_30496_MOESM2_ESM.xls, sheet 1
View BVdb publication page



Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.

Journal Of Hepatology
Sumazin, Pavel P; Peters, Tricia L TL; Sarabia, Stephen F SF; Kim, Hyunjae R HR; Urbicain, Martin M; Hollingsworth, Emporia Faith EF; Alvarez, Karla R KR; Perez, Cintia R CR; Pozza, Alice A; Najaf Panah, Mohammad Javad MJ; Epps, Jessica L JL; Scorsone, Kathy K; Zorman, Barry B; Katzenstein, Howard H; O'Neill, Allison F AF; Meyers, Rebecka R; Tiao, Greg G; Geller, Jim J; Ranganathan, Sarangarajan S; Rangaswami, Arun A AA; Woodfield, Sarah E SE; Goss, John A JA; Vasudevan, Sanjeev A SA; Heczey, Andras A; Roy, Angshumoy A; Fisher, Kevin E KE; Alaggio, Rita R; Patel, Kalyani R KR; Finegold, Milton J MJ; López-Terrada, Dolores H DH
Publication Date: 2022-10

Variant appearance in text: MAPK1: 961G>A; D321N
PubMed Link: 35577029
Variant Present in the following documents:
  • mmc5.xlsx, sheet 1
View BVdb publication page



Precision drugging of the MAPK pathway in head and neck cancer.

Npj Genomic Medicine
Ngan, Hoi-Lam HL; Law, Chun-Ho CH; Choi, Yannie Chung Yan YCY; Chan, Jenny Yu-Sum JY; Lui, Vivian Wai Yan VWY
Publication Date: 2022-03-16

Variant appearance in text: MAPK1: D321N
PubMed Link: 35296678
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.

Jid Innovations
Abdulla, Farah R FR; Zhang, Weiwei W; Wu, Xiwei X; Honda, Kord K; Qin, Hanjun H; Cho, Hyejin H; Querfeld, Christiane C; Zain, Jasmine J; Rosen, Steven Terry ST; Chan, Wing C WC; Parekh, Vishwas V; Song, Joo Y JY
Publication Date: 2022-01

Variant appearance in text: MAPK1: D321N
PubMed Link: 34977845
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.

Jid Innovations : Skin Science From Molecules To Population Health
Abdulla, Farah R FR; Zhang, Weiwei W; Wu, Xiwei X; Honda, Kord K; Qin, Hanjun H; Cho, Hyejin H; Querfeld, Christiane C; Zain, Jasmine J; Rosen, Steven Terry ST; Chan, Wing C WC; Parekh, Vishwas V; Song, Joo Y JY
Publication Date: 2022-01

Variant appearance in text: MAPK1: D321N
PubMed Link: 34977845
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Spatially interacting phosphorylation sites and mutations in cancer.

Nature Communications
Huang, Kuan-Lin KL; Scott, Adam D AD; Zhou, Daniel Cui DC; Wang, Liang-Bo LB; Weerasinghe, Amila A; Elmas, Abdulkadir A; Liu, Ruiyang R; Wu, Yige Y; Wendl, Michael C MC; Wyczalkowski, Matthew A MA; Baral, Jessika J; Sengupta, Sohini S; Lai, Chin-Wen CW; Ruggles, Kelly K; Payne, Samuel H SH; Raphael, Benjamin B; Fenyö, David D; Chen, Ken K; Mills, Gordon G; Ding, Li L
Publication Date: 2021-04-19

Variant appearance in text: MAPK1: D321N
PubMed Link: 33875650
Variant Present in the following documents:
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 1
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division.

The Journal Of Biological Chemistry
Guo, Xiao X; Ramirez, Ivan I; Garcia, Yenni A YA; Velasquez, Erick F EF; Gholkar, Ankur A AA; Cohn, Whitaker W; Whitelegge, Julian P JP; Tofig, Bobby B; Damoiseaux, Robert R; Torres, Jorge Z JZ
Publication Date: 2021

Variant appearance in text: ERK2: D321N
PubMed Link: 33865857
Variant Present in the following documents:
  • mmc3.pdf
View BVdb publication page



Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Molecular Diagnosis & Therapy
de Kort, W W B WWB; Spelier, S S; Devriese, L A LA; van Es, R J J RJJ; Willems, S M SM
Publication Date: 2021-03

Variant appearance in text: MAPK1: D321N
PubMed Link: 33686517
Variant Present in the following documents:
  • 40291_2021_Article_518.pdf
  • 40291_2021_518_MOESM1_ESM.pdf
View BVdb publication page



Toward Developing Intuitive Rules for Protein Variant Effect Prediction Using Deep Mutational Scanning Data.

Acs Omega
Sruthi, Cheloor Kovilakam CK; Balaram, Hemalatha H; Prakash, Meher K MK
Publication Date: 2020-11-24

Variant appearance in text: MAPK1: D321N
PubMed Link: 33251402
Variant Present in the following documents:
  • ao0c02402_si_002.xls, sheet 2
View BVdb publication page



Identification of relevant genetic alterations in cancer using topological data analysis.

Nature Communications
Rabadán, Raúl R; Mohamedi, Yamina Y; Rubin, Udi U; Chu, Tim T; Alghalith, Adam N AN; Elliott, Oliver O; Arnés, Luis L; Cal, Santiago S; Obaya, Álvaro J ÁJ; Levine, Arnold J AJ; Cámara, Pablo G PG
Publication Date: 2020-07-30

Variant appearance in text: MAPK1: D321N
PubMed Link: 32732999
Variant Present in the following documents:
  • 41467_2020_17659_MOESM3_ESM.xls, sheet 1
View BVdb publication page



Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.

American Journal Of Human Genetics
Motta, Marialetizia M; Pannone, Luca L; Pantaleoni, Francesca F; Bocchinfuso, Gianfranco G; Radio, Francesca Clementina FC; Cecchetti, Serena S; Ciolfi, Andrea A; Di Rocco, Martina M; Elting, Mariet W MW; Brilstra, Eva H EH; Boni, Stefania S; Mazzanti, Laura L; Tamburrino, Federica F; Walsh, Larry L; Payne, Katelyn K; Fernández-Jaén, Alberto A; Ganapathi, Mythily M; Chung, Wendy K WK; Grange, Dorothy K DK; Dave-Wala, Ashita A; Reshmi, Shalini C SC; Bartholomew, Dennis W DW; Mouhlas, Danielle D; Carpentieri, Giovanna G; Bruselles, Alessandro A; Pizzi, Simone S; Bellacchio, Emanuele E; Piceci-Sparascio, Francesca F; Lißewski, Christina C; Brinkmann, Julia J; Waclaw, Ronald R RR; Waisfisz, Quinten Q; van Gassen, Koen K; Wentzensen, Ingrid M IM; Morrow, Michelle M MM; Álvarez, Sara S; Martínez-García, Mónica M; De Luca, Alessandro A; Memo, Luigi L; Zampino, Giuseppe G; Rossi, Cesare C; Seri, Marco M; Gelb, Bruce D BD; Zenker, Martin M; Dallapiccola, Bruno B; Stella, Lorenzo L; Prada, Carlos E CE; Martinelli, Simone S; Flex, Elisabetta E; Tartaglia, Marco M
Publication Date: 2020-09-03

Variant appearance in text: MAPK1: Asp321Asn
PubMed Link: 32721402
Variant Present in the following documents:
  • Main text
View BVdb publication page



mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: MAPK1: D321N
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.

Life Science Alliance
Ngan, Hoi-Lam HL; Liu, Yuchen Y; Fong, Andrew Yuon AY; Poon, Peony Hiu Yan PHY; Yeung, Chun Kit CK; Chan, Sharon Suet Man SSM; Lau, Alexandria A; Piao, Wenying W; Li, Hui H; Tse, Jessie Sze Wing JSW; Lo, Kwok-Wai KW; Chan, Sze Man SM; Su, Yu-Xiong YX; Chan, Jason Ying Kuen JYK; Lau, Chin Wang CW; Mills, Gordon B GB; Grandis, Jennifer Rubin JR; Lui, Vivian Wai Yan VWY
Publication Date: 2020-06

Variant appearance in text: MAPK1: D321N
PubMed Link: 32381551
Variant Present in the following documents:
  • Main text
View BVdb publication page



Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma.

Npj Genomic Medicine
Ngan, Hoi-Lam HL; Poon, Peony Hiu Yan PHY; Su, Yu-Xiong YX; Chan, Jason Ying Kuen JYK; Lo, Kwok-Wai KW; Yeung, Chun Kit CK; Liu, Yuchen Y; Wong, Eileen E; Li, Hui H; Lau, Chin Wang CW; Piao, Wenying W; Lui, Vivian Wai Yan VWY
Publication Date: 2020

Variant appearance in text: MAPK1: D321N
PubMed Link: 32351709
Variant Present in the following documents:
  • Main text
View BVdb publication page



Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects.

Nature Communications
Tomasovic, Angela A; Brand, Theresa T; Schanbacher, Constanze C; Kramer, Sofia S; Hümmert, Martin W MW; Godoy, Patricio P; Schmidt-Heck, Wolfgang W; Nordbeck, Peter P; Ludwig, Jonas J; Homann, Susanne S; Wiegering, Armin A; Shaykhutdinov, Timur T; Kratz, Christoph C; Knüchel, Ruth R; Müller-Hermelink, Hans-Konrad HK; Rosenwald, Andreas A; Frey, Norbert N; Eichler, Jutta J; Dobrev, Dobromir D; El-Armouche, Ali A; Hengstler, Jan G JG; Müller, Oliver J OJ; Hinrichs, Karsten K; Cuello, Friederike F; Zernecke, Alma A; Lorenz, Kristina K
Publication Date: 2020-04-07

Variant appearance in text: ERK2: D321N
PubMed Link: 32265441
Variant Present in the following documents:
  • Main text
  • 41467_2020_Article_15505.pdf
  • 41467_2020_15505_MOESM2_ESM.pdf
View BVdb publication page



Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.

Communications Biology
Dong, Xiaobao X; Huang, Dandan D; Yi, Xianfu X; Zhang, Shijie S; Wang, Zhao Z; Yan, Bin B; Chung Sham, Pak P; Chen, Kexin K; Jun Li, Mulin M
Publication Date: 2020-01-07

Variant appearance in text: MAPK1: 961G>A; D321N
PubMed Link: 31925297
Variant Present in the following documents:
  • 42003_2019_736_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Functional divergence caused by mutations in an energetic hotspot in ERK2.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Taylor, Clinton A CA; Cormier, Kevin W KW; Keenan, Shannon E SE; Earnest, Svetlana S; Stippec, Steve S; Wichaidit, Chonlarat C; Juang, Yu-Chi YC; Wang, Junmei J; Shvartsman, Stanislav Y SY; Goldsmith, Elizabeth J EJ; Cobb, Melanie H MH
Publication Date: 2019-07-30

Variant appearance in text: ERK2: D321N
PubMed Link: 31296562
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs.

Genes & Development
Yue, Jingyin J; Lai, Fan F; Beckedorff, Felipe F; Zhang, Anda A; Pastori, Chiara C; Shiekhattar, Ramin R
Publication Date: 2017-09-01

Variant appearance in text: ERK2: D321N
PubMed Link: 28982763
Variant Present in the following documents:
  • Main text
  • 1809.pdf
View BVdb publication page



APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.

Nature Communications
Chen, Ting-Wen TW; Lee, Chi-Ching CC; Liu, Hsuan H; Wu, Chi-Sheng CS; Pickering, Curtis R CR; Huang, Po-Jung PJ; Wang, Jing J; Chang, Ian Yi-Feng IY; Yeh, Yuan-Ming YM; Chen, Chih-De CD; Li, Hsin-Pai HP; Luo, Ji-Dung JD; Tan, Bertrand Chin-Ming BC; Chan, Timothy En Haw TEH; Hsueh, Chuen C; Chu, Lichieh Julie LJ; Chen, Yi-Ting YT; Zhang, Bing B; Yang, Chia-Yu CY; Wu, Chih-Ching CC; Hsu, Chia-Wei CW; See, Lai-Chu LC; Tang, Petrus P; Yu, Jau-Song JS; Liao, Wei-Chao WC; Chiang, Wei-Fan WF; Rodriguez, Henry H; Myers, Jeffrey N JN; Chang, Kai-Ping KP; Chang, Yu-Sun YS
Publication Date: 2017-09-06

Variant appearance in text: MAPK1: D321N
PubMed Link: 28878238
Variant Present in the following documents:
  • 41467_2017_493_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma.

Oncotarget
Chakraborty, Rikhia R; Hampton, Oliver A OA; Abhyankar, Harshal H; Zinn, Daniel J DJ; Grimes, Amanda A; Skull, Brooks B; Eckstein, Olive O; Mahmood, Nadia N; Wheeler, David A DA; Lopez-Terrada, Dolores D; Peters, Tricia L TL; Hicks, John M JM; Elghetany, Tarek T; Krance, Robert R; Poulikakos, Poulikos I PI; Merad, Miriam M; McClain, Kenneth L KL; Allen, Carl E CE; Parsons, Donald W DW
Publication Date: 2017-07-11

Variant appearance in text: ERK2: 961G>A
PubMed Link: 28512266
Variant Present in the following documents:
  • Main text
  • oncotarget-08-46065-s001.pdf
View BVdb publication page



Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants.

Cell Reports
Brenan, Lisa L; Andreev, Aleksandr A; Cohen, Ofir O; Pantel, Sasha S; Kamburov, Atanas A; Cacchiarelli, Davide D; Persky, Nicole S NS; Zhu, Cong C; Bagul, Mukta M; Goetz, Eva M EM; Burgin, Alex B AB; Garraway, Levi A LA; Getz, Gad G; Mikkelsen, Tarjei S TS; Piccioni, Federica F; Root, David E DE; Johannessen, Cory M CM
Publication Date: 2016-10-18

Variant appearance in text: ERK2: D321N
PubMed Link: 27760319
Variant Present in the following documents:
  • Main text
View BVdb publication page



ERK2 phosphorylates Krüppel-like factor 8 protein at serine 48 to maintain its stability.

American Journal Of Cancer Research
Lahiri, Satadru K SK; Lu, Heng H; Mukherjee, Debarati D; Yu, Lin L; Zhao, Jihe J
Publication Date: 2016

Variant appearance in text: ERK2: D321N
PubMed Link: 27293988
Variant Present in the following documents:
  • Main text
View BVdb publication page



PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions.

Plos Computational Biology
Bendl, Jaroslav J; Musil, Miloš M; Štourač, Jan J; Zendulka, Jaroslav J; Damborský, Jiří J; Brezovský, Jan J
Publication Date: 2016-05

Variant appearance in text: MAPK1: D321N
PubMed Link: 27224906
Variant Present in the following documents:
  • pcbi.1004962.s005.xlsx, sheet 3
View BVdb publication page



Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase.

The Journal Of Biological Chemistry
Qi, Haoling H; Prabakaran, Sudhakaran S; Cantrelle, François-Xavier FX; Chambraud, Béatrice B; Gunawardena, Jeremy J; Lippens, Guy G; Landrieu, Isabelle I
Publication Date: 2016-04-01

Variant appearance in text: ERK2: D321N
PubMed Link: 26858248
Variant Present in the following documents:
  • Main text
View BVdb publication page



Recurrent inactivating RASA2 mutations in melanoma.

Nature Genetics
Arafeh, Rand R; Qutob, Nouar N; Emmanuel, Rafi R; Keren-Paz, Alona A; Madore, Jason J; Elkahloun, Abdel A; Wilmott, James S JS; Gartner, Jared J JJ; Di Pizio, Antonella A; Winograd-Katz, Sabina S; Sindiri, Sivasish S; Rotkopf, Ron R; Dutton-Regester, Ken K; Johansson, Peter P; Pritchard, Antonia L AL; Waddell, Nicola N; Hill, Victoria K VK; Lin, Jimmy C JC; Hevroni, Yael Y; Rosenberg, Steven A SA; Khan, Javed J; Ben-Dor, Shifra S; Niv, Masha Y MY; Ulitsky, Igor I; Mann, Graham J GJ; Scolyer, Richard A RA; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2015-12

Variant appearance in text: ERK2: D321N
PubMed Link: 26502337
Variant Present in the following documents:
  • NIHMS65345-supplement-Supplementary_table_3.xlsx, sheet 2
View BVdb publication page



Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Nature Genetics
Krauthammer, Michael M; Kong, Yong Y; Bacchiocchi, Antonella A; Evans, Perry P; Pornputtapong, Natapol N; Wu, Cen C; McCusker, James P JP; Ma, Shuangge S; Cheng, Elaine E; Straub, Robert R; Serin, Merdan M; Bosenberg, Marcus M; Ariyan, Stephan S; Narayan, Deepak D; Sznol, Mario M; Kluger, Harriet M HM; Mane, Shrikant S; Schlessinger, Joseph J; Lifton, Richard P RP; Halaban, Ruth R
Publication Date: 2015-09

Variant appearance in text: MAPK1: D321N
PubMed Link: 26214590
Variant Present in the following documents:
  • Main text
View BVdb publication page



ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

Cancer Research
Goetz, Eva M EM; Ghandi, Mahmoud M; Treacy, Daniel J DJ; Wagle, Nikhil N; Garraway, Levi A LA
Publication Date: 2014-12-01

Variant appearance in text: ERK2: D321N
PubMed Link: 25320010
Variant Present in the following documents:
  • Main text
View BVdb publication page



A highly recurrent RPS27 5'UTR mutation in melanoma.

Oncotarget
Dutton-Regester, Ken K; Gartner, Jared J JJ; Emmanuel, Rafi R; Qutob, Nouar N; Davies, Michael A MA; Gershenwald, Jeffrey E JE; Robinson, William W; Robinson, Steven S; Rosenberg, Steven A SA; Scolyer, Richard A RA; Mann, Graham J GJ; Thompson, John F JF; Hayward, Nicholas K NK; Samuels, Yardena Y
Publication Date: 2014-05-30

Variant appearance in text: ERK2: D321N
PubMed Link: 24913145
Variant Present in the following documents:
  • oncotarget-05-2912-s003.xlsx, sheet 1
View BVdb publication page



Copper is required for oncogenic BRAF signalling and tumorigenesis.

Nature
Brady, Donita C DC; Crowe, Matthew S MS; Turski, Michelle L ML; Hobbs, G Aaron GA; Yao, Xiaojie X; Chaikuad, Apirat A; Knapp, Stefan S; Xiao, Kunhong K; Campbell, Sharon L SL; Thiele, Dennis J DJ; Counter, Christopher M CM
Publication Date: 2014-05-22

Variant appearance in text: ERK2: D321N
PubMed Link: 24717435
Variant Present in the following documents:
  • Main text
View BVdb publication page